ArticleJournal of cancer research and clinical oncology2014

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.

Evangelia Razis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.